Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.63 |
| ▸ | CASP1 | P29466 | 1/20 | 0.63 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.63 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | GLA | P06280 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | ACLY | P53396 | 1/20 | 0.50 |
| ▸ | PTPRC | P08575 | 1/20 | 0.50 |
| ▸ | PTPRG | P23470 | 1/20 | 0.50 |
| ▸ | SORT1 | Q99523 | 3/20 | 0.49 |
| ▸ | FLT1 | P17948 | 1/20 | 0.49 |
| ▸ | FLT4 | P35916 | 1/20 | 0.49 |
| ▸ | KDR | P35968 | 1/20 | 0.49 |
| ▸ | MYC | P01106 | 2/20 | 0.49 |
| ▸ | NR4A1 | P22736 | 2/20 | 0.49 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | DHODH | Q02127 | 2/20 | 0.45 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.45 |
| ▸ | METAP2 | P50579 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29989222 | 1.00 | TSHR (0.63) | TSHRCASP1SMN1; SMN2KDM4EGLA | |
| SCHEMBL30249448 | 0.83 | ALDH1A1 (0.63) | KDM4EGLAALDH1A1PTPRCPTPRG | |
| SCHEMBL30526110 | 0.83 | FLT1 (0.49) | TSHRCASP1SMN1; SMN2KDM4EGLA | |
| SCHEMBL257466 | 0.83 | FLT1 (0.49) | TSHRCASP1SMN1; SMN2KDM4EGLA | |
| SCHEMBL18214 | 0.83 | ALDH1A1 (0.63) | KDM4EGLAALDH1A1PTPRCPTPRG | |
| SCHEMBL1328959 | 0.81 | DGAT1 (0.60) | TSHRCASP1SMN1; SMN2KDM4EGLA | |
| Hydrochloric Acid SCHEMBL1631822 | 0.81 | ALDH1A1 (0.61) | KDM4EGLAALDH1A1PTPRCPTPRG | |
| SCHEMBL10462650 | 0.81 | ALDH1A1 (0.61) | KDM4EGLAALDH1A1PTPRCPTPRG | |
| SCHEMBL332423 | 0.81 | ALDH1A1 (0.50) | TSHRCASP1SMN1; SMN2ALDH1A1FLT1 | |
| SCHEMBL29533520 | 0.81 | ALDH1A1 (0.50) | TSHRCASP1SMN1; SMN2ALDH1A1FLT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1129 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118184679-A | Photothermal agent and preparation method thereof, photothermal nanoparticle and preparation method thereof, insulating material and self-repairing method of insulating material | 中国石油天然气股份有限公司 | 2024-06-14 | — | — | CN | claimed |
| CN-110002989-B | Preparation method of high-selectivity 5-bromo-2-chlorobenzoic acid | 河北合佳医药科技集团股份有限公司 | 2021-06-22 | — | — | CN | claimed |
| CN-103008919-B | Low-silver halogen-free lead-free solder paste | CHENZHOU GOLD ARROW SOLDER CO LTD | 2015-05-27 | — | — | CN | claimed |
| CN-103008919-A | Low-silver halogen-free lead-free solder paste | CHENZHOU GOLD ARROW SOLDER CO LTD | 2013-04-03 | — | — | CN | claimed |
| EP-1438295-B1 | AZOLE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | MERCK SERONO SA (CH) | 2012-08-15 | — | — | EP | claimed |
| CN-101543943-B | Leadless rosin core low-halogen no-clean scaling powder and method for preparing same | YUNNAN TIN COMPANY GROUP HOLDING CO LTD | 2012-07-11 | — | — | CN | claimed |
| CN-101543943-A | Leadless rosin core low-halogen no-clean scaling powder and method for preparing same | YUNNAN TIN COMPANY GROUP HOLDI | 2009-09-30 | — | — | CN | claimed |
| EP-1216045-A2 | VASOPRESSIN AGONIST FORMULATION AND PROCESS | American Cynamid Company (US) | 2002-06-26 | — | — | EP | claimed |
| WO-2001022969-A2 | VASOPRESSIN AGONIST FORMULATION AND PROCESS | AMERICAN CYNAMID COMPANY (US) | 2001-04-05 | — | — | WO | claimed |
| CN-122079899-A | Application of pharmaceutical composition in preparation of medicines for preventing or treating diseases related to Sirttail 7 protein | — | 2026-05-26 | — | — | CN | disclosed |
| US-20260109676-A1 | HETEROCYCLIC COMPOUNDS AND RELATED METHODS | RECURSION PHARMACEUTICALS INC (US) | 2026-04-23 | — | — | US | disclosed |
| US-20260070932-A1 | INHIBITORS OF COMPLEMENT FACTORS AND USES THEREOF | ANNEXON INC (US) | 2026-03-12 | — | — | US | disclosed |
| EP-4696692-A1 | CRYSTAL OF NITROGEN-CONTAINING HETEROCYCLIC COMPOUND HAVING NRF2 ACTIVATION EFFECT | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2026-02-18 | — | — | EP | disclosed |
| US-12528779-B2 | Heterocyclic compounds and related methods | RECURSION PHARMACEUTICALS, INC. (US) | 2026-01-20 | — | — | US | disclosed |
| CN-1085221-A | Bactericide for preventing and treating plant take-all disease | MONSANTO CO (US) | 1994-04-13 | — | — | CN | disclosed |
| WO-1993007751-A1 | FUNGICIDES FOR THE CONTROL OF TAKE-ALL DISEASE OF PLANTS | MONSANTO COMPANY (US) | 1993-04-29 | — | — | WO | disclosed |
| EP-0538231-A1 | Fungicides for the control of take-all disease of plants | MONSANTO COMPANY (US) | 1993-04-21 | — | — | EP | disclosed |
| EP-0520815-A2 | Method for producing ortho-alkoxybenzoic acid | NIPPON CHEMICAL INDUSTRIAL COMPANY LIMITED (JP) | 1992-12-30 | — | — | EP | disclosed |
| EP-0471516-A1 | Tricyclic heterocyclic derivatives | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1992-02-19 | — | — | EP | disclosed |
| US-4959363-A | HERPES VIRUS | STERLING DRUG INC. (US) | 1990-09-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260109676-A1 | HETEROCYCLIC COMPOUNDS AND RELATED METHODS | SLC10A1, SCN1B, HSD3B2 | TSHR 620/4885CASP1 2222/4885SMN1; SMN2 133/4885 |
| US-12528779-B2 | Heterocyclic compounds and related methods | SLC10A1, SCN1B, NPY5R | TSHR 942/4885CASP1 1168/4885SMN1; SMN2 221/4885 |
| US-20260070932-A1 | INHIBITORS OF COMPLEMENT FACTORS AND USES THEREOF | CFH, CFB, C5 | TSHR 204/4885CASP1 1976/4885SMN1; SMN2 1451/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.